论文部分内容阅读
第六届美国国家癌症协会—欧洲研究与治疗肿瘤组织抗癌治疗新药专题讨论会于1989年3月7日～10日在荷兰首都阿姆斯特丹召开。这个专题讨论会由美国国家癌症协会—欧洲研究与治疗肿瘤组织机构召集和参加的。该专题讨论会全面地评估临床前期和Ⅰ/Ⅱ期临床抗癌新药。该会议研究不限制在特殊种类抗癌药,还包括提出和讨论大批各种新抗癌药、生物反应调节基因、生化调节因子和变异诱发剂。专题讨论会内容还包括药物设计和研究开发方面的新策略和目标、新筛选方法以及克服抗药性的途径。这次会议目的在于促进研究和开发新抗
The Sixth American National Cancer Institute - European Research and Treatment Oncology New anticancer medicine symposium was held in Amsterdam, the capital of the Netherlands from March 7 to March 10, 1989. The symposium was convened and participated by the National Cancer Institute of the European Union for Research and Treatment of Tumors. The symposium will comprehensively evaluate the preclinical and phase Ⅰ / Ⅱ clinical anti-cancer drugs. The conference’s study is not limited to a specific category of anticancer drugs, but also includes the presentation and discussion of a wide range of new anticancer drugs, bioreactor genes, biochemical regulators and mutagens. The symposium will also include new strategies and targets for drug design and research and development, new screening methods, and ways to overcome resistance. The purpose of this meeting is to promote research and development of new anti-drugs